Showing 521-530 of 19239 results for "".
Interventions Targeting Impaired Glucose Tolerance
https://reachmd.com/programs/diabetes-discourse/interventions-targeting-impaired-glucose-tolerance/5010/The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San DChoosing Between Insulin and Incretin Therapies
https://reachmd.com/programs/diabetes-discourse/choosing-between-insulin-and-incretin-therapies/6170/When should healthcare professionals treating patients with type 2 diabetes consider using insulin or incretin treatment or both? Join host Dr. Steven Edelman and his guest, president-elect of the American Diabetes Association and professor of medicine at Tulane University, Dr. Vivian Fonseca, as thInsulin-Like Effects on Exercising Muscles
https://reachmd.com/programs/focus-on-sports-medicine/insulin-like-effects-on-exercising-muscles/3899/Dr. Laurie Goodyear, a senior investigator and head of the section on metabolism at the Joslin Diabetes Center in Boston, discusses with host Dr. Larry Kaskel how exercise impedes the development of type 2 diabetes. Tune in to hear the implications of Dr. Goodyear's research on exercise and how it wIs a Low-Carb, High-Fat Diet the Key to Diabetic Management?
https://reachmd.com/programs/clinicians-roundtable/is-a-low-carb-high-fat-diet-the-key-to-diabetic-management/10040/Dr. Sarah Hallberg discusses how a simple change in diet can lead to improved blood sugar levels and better management of diabetes.Exploring COVID-19 in Diabetes: A Look at Disease Management & Risk
https://reachmd.com/programs/diabetes-discourse/exploring-covid-19-in-diabetes-a-look-at-disease-management-risk/12585/Should patients with diabetes be concerned about getting the COVID-19 vaccine?Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
https://reachmd.com/programs/diabetes-discourse/understanding-dapagliflozin-examining-its-use-in-chronic-kidney-disease/12251/Can a treatment option used for type 2 diabetes help those with chronic kidney disease?Coping Strategies for Patients Growing up With Chronic Illness
https://reachmd.com/programs/clinicians-roundtable/coping-strategies-for-patients-growing-up-with-chronic-illness/3412/Better technology and treatments mean that people with serious childhood illnesses such as cystic fibrosis and type one diabetes are reaching adulthood in unprecedented numbers. That means they are also struggling with college, relationships, fertility and employment. Laurie Edwards, a health journAssessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
https://reachmd.com/programs/diabetes-discourse/assessing-glucose-control-reducing-cardiovascular-risk-in-patients-with-diabetes/12769/Could glucose control mitigate cardiovascular risk in diabetic patients?Newt Gingrich: Improving Care for Diabetics
https://reachmd.com/programs/clinicians-roundtable/newt-gingrich-improving-care-for-diabetics/1338/Perhaps best known for his Contract with America and the subsequent Republican control of the House of Representatives for 12 years, many physicians do not know how strong a healthcare advocate former Speaker of the House Newt Gingrinch has become, or the tranformations in health policy he began pioWhat’s Happening in Hypoglycemia?
https://reachmd.com/programs/diabetes-discourse/whats-happening-in-hypoglycemia/4692/The frequency of hypoglycemic events for both type 1 and type 2 diabetics increases due to tight blood glucose control and more intensive treatment schedules. The disease differs significantly between type 1 and type 2 in the body’s defense mechanism of decreasing insulin concentration. Join host Dr